Geron Corporation – Material Contracts Watch

from 10-Q 12 pages Employment Agreement

from 10-Q >50 pages Material contract

from 10-Q ~50 pages Geron Corporation Non-Employee Director Compensation Policy Originally Adopted by the Board of Directors: March 10, 2014 Amended by the Board of Directors: February 12, 2015, May 6, 2015, February 11, 2016, January 31, 2018, May 15, 2018, October 1, 2018, January 30, 2019, February 12, 2020, February 16, 2022, March 7, 2022, February 14, 2024, March 6, 2025, May 4, 2025, February 17, 2026 and March 12, 2026 Each Member of the Board of Directors (The “Board”) of Geron Corporation (The “Company”) Who Is a Non-Employee Director (As Defined in the Geron Corporation 2018 Equity Incentive Plan (The “2018 Plan”)) Shall Be Eligible to Receive Cash and Equity Compensation as Set Forth in This Geron Corporation Non-Employee Director Compensation Policy (This “Policy”). the Cash and Equity Compensation Described in This Policy Shall Be Paid or Granted, as Applicable, Automatically and Without Further Action of the Board to Each Non-Employee Director Who Is Eligible to Receive Such Cash or Equity Compensation, Unless Such Non-Employee Director Declines the Receipt of Such Cash or Equity Compensation by Written Notice to the Company. This Policy, as Amended, Is Effective as of January 1, 2026, and Shall Remain in Effect Until It Is Revised or Rescinded by Further Action of the Board. Capitalized Terms Not Explicitly Defined in This Policy but Defined in the 2018 Plan Shall Have the Same Definitions as in the 2018 Plan, Except When Specific Reference Is Made to the Directors’ Market Value Stock Purchase Plan (The “Market Value Stock Plan”), in Which Case Such Terms Shall Have the Definitions Set Forth in the Market Value Stock Plan. 1.cash Compensation. (A)annual Retainers. Each Non-Employee Director Shall Be Eligible to Receive the Following Annual Retainers for Service as (I) an Individual, Member and/or Chairperson of the Board and (II) an Individual, Member or Chairperson of a Committee of the Board (“Committee”) Set Forth Below, as Applicable

from 10-K 9 pages Employment Agreement

from 10-K 11 pages Employment Agreement

from 10-K 10 pages First Amendment

from 10-K ~50 pages Board or Committee Type of Retainer* Amount (Per Year) Board Chair $40,000 Lead Independent Director $30,000 Member $50,000 Audit Committee Chair $25,000 Member (Non-Chair) $12,500 Compensation Committee Chair $15,000 Member (Non-Chair) $7,500 Nominating and Corporate Governance Committee Chair $10,000 Member (Non-Chair) $5,000 Strategic Committee Chair $15,000 Member (Non-Chair) $7,500

from 8-K 21 pages Amended 2018 Inducement Award Plan

from 8-K 16 pages Geron Corporation Amended and Restated Severance Plan

from 8-K 10 pages Employment Agreement

from 8-K 12 pages Geron Corporation 2014 Employee Stock Purchase Plan Adopted by the Board of Directors: March 10, 2014 Approved by the Stockholders: May 20, 2014 Amended by the Board of Directors: February 16, 2022 Approved by the Stockholders: May 10, 2022 Amended by the Board of Directors: March 6, 2025 Approved by the Stockholders: May 21, 2025

from 8-K 21 pages Geron Corporation 2018 Equity Incentive Plan Adopted by the Board of Directors: March 27, 2018 Approved by the Stockholders: May 15, 2018 Amended by the Board of Directors: February 12, 2020 Approved by the Stockholders: June 5, 2020 Amended by the Board of Directors: February 2, 2021 Approved by the Stockholders: May 11, 2021 Amended by the Board of Directors: February 16, 2022 Approved by the Stockholders: May 10, 2022 Amended by the Board of Directors: March 18, 2023 Approved by the Stockholders: May 31, 2023 Amended by the Board of Directors: March 13, 2025 Approved by the Stockholders: May 21, 2025

from 10-Q 3 pages March 14, 2025 Dawn C. Bir Re: Employment Terms

from 10-Q 3 pages Geron Corporation Non-Employee Director Compensation Policy Originally Adopted by the Board of Directors: March 10, 2014 Amended by the Board of Directors: February 12, 2015, May 6, 2015, February 11, 2016, January 31, 2018, May 15, 2018, October 1, 2018, January 30, 2019, February 12, 2020, February 16, 2022, March 7, 2022, February 14, 2024, March 6, 2025 and May 4, 2025

from 10-K 44 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***]”. Such Identified Information Has Been Excluded From This Exhibit Because It Is (I) Not Material and (II) the Type That the Registrant Customarily and Actually Treats as Private and Confidential. Revenue Participation Right Purchase and Sale Agreement by and Between Geron Corporation and Royalty Pharma Development Funding, LLC Dated as of November 1, 2024

from 10-K 12 pages Employment Agreement

from 10-K 13 pages Geron Corporation Rsu Award Grant Notice

from 10-K 20 pages Amended 2018 Inducement Award Plan

from 10-K 13 pages Geron Corporation Rsu Award Grant Notice

from 10-Q 11 pages Employment Agreement